RESUMEN
Fish represent the planet's most diverse group of vertebrates and they can be exposed to a wide range of pharmaceuticals. For practical reasons, extrapolation of pharmaceutical effects from 'model' species to other fish species is adopted in risk assessment. Here, we critically assess this approach. First, we show that between 65% and 86% of human drug targets are evolutionarily conserved in 12 diverse fish species. Focusing on nuclear steroid hormone receptors, we further show that the sequence of the ligand binding domain that plays a key role in drug potency is highly conserved, but there is variation between species. This variation for the oestrogen receptor, however, does not obviously account for observed differences in receptor activation. Taking the synthetic oestrogen ethinyloestradiol as a test case, and using life-table-response experiments, we demonstrate significant reductions in population growth in fathead minnow and medaka, but not zebrafish, for environmentally relevant exposures. This finding contrasts with zebrafish being ranked as more ecologically susceptible, according to two independent life-history analyses. We conclude that while most drug targets are conserved in fish, evolutionary divergence in drug-target activation, physiology, behaviour and ecological life history make it difficult to predict population-level effects. This justifies the conventional use of at least a 10× assessment factor in pharmaceutical risk assessment, to account for differences in species susceptibility.
Asunto(s)
Peces/genética , Peces/fisiología , Preparaciones Farmacéuticas/química , Contaminantes Químicos del Agua/toxicidad , Secuencia de Aminoácidos , Animales , Evolución Biológica , Ecosistema , Modelos Biológicos , Filogenia , Alineación de Secuencia , Especificidad de la Especie , Contaminantes Químicos del Agua/químicaRESUMEN
Anti-neutrophil cytoplasmic antibodies (ANCA) are thought to be pathogenic in ANCA-associated vasculitis (AAV) by stimulating polymorphonuclear leucocytes (PMNs) to degranulate and produce reactive oxygen species (ROS). The aim of this study was to investigate if PMNs from AAV patients are stimulated more readily by ANCA compared with PMNs from healthy controls (HCs). Differences in ANCA characteristics that can account for different stimulation potential were also studied. PMNs from five AAV patients and five HCs were stimulated with 10 different immunoglobulins (Ig)Gs, purified from PR3-ANCA-positive patients, and ROS production, degranulation and neutrophil extracellular trap (NET) formation was measured. ANCA levels, affinity and clinical data of the AAV donors were recorded. The results show that PMNs from AAV patients produce more intracellular ROS (P = 0·019), but degranulate to a similar extent as PMNs from HCs. ROS production correlated with NET formation. Factors that may influence the ability of ANCA to activate PMNs include affinity and specificity for N-terminal epitopes. In conclusion, our results indicate that PMNs from AAV patients in remission behave quite similarly to HC PMNs, with the exception of a greater intracellular ROS production. This could contribute to more extensive NET formation and thus an increased exposure of the ANCA autoantigens to the immune system.
Asunto(s)
Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/inmunología , Anticuerpos Anticitoplasma de Neutrófilos/inmunología , Neutrófilos/inmunología , Anciano , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/metabolismo , Degranulación de la Célula/inmunología , Epítopos/inmunología , Humanos , Inmunoglobulina G/inmunología , Persona de Mediana Edad , Neutrófilos/metabolismo , Especies Reactivas de Oxígeno/metabolismoRESUMEN
The presence of pharmaceuticals in the aquatic environment, and the concerns for negative effects on aquatic organisms, has gained increasing attention over the last years. As ecotoxicity data are lacking for most active pharmaceutical ingredients (APIs), it is important to identify strategies to prioritise APIs for ecotoxicity testing and environmental monitoring. We have used nine previously proposed prioritisation schemes, both risk- and hazard-based, to rank 582 APIs. The similarities and differences in overall ranking results and input data were compared. Moreover, we analysed how well the methods ranked seven relatively well-studied APIs. It is concluded that the hazard-based methods were more successful in correctly ranking the well-studied APIs, but the fish plasma model, which includes human pharmacological data, also showed a high success rate. The results of the analyses show that the input data availability vary significantly; some data, such as logP, are available for most API while information about environmental concentrations and bioconcentration are still scarce. The results also suggest that the exposure estimates in risk-based methods need to be improved and that the inclusion of effect measures at first-tier prioritisation might underestimate risks. It is proposed that in order to develop an adequate prioritisation scheme, improved data on exposure such as degradation and sewage treatment removal and bioconcentration ability should be further considered. The use of ATC codes may also be useful for the development of a prioritisation scheme that includes the mode of action of pharmaceuticals and, to some extent, mixture effects.
Asunto(s)
Monitoreo del Ambiente , Preparaciones Farmacéuticas/análisis , Contaminantes Químicos del Agua/análisis , Animales , Bases de Datos Factuales , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Ecotoxicología , Exposición a Riesgos Ambientales/efectos adversos , Monitoreo del Ambiente/métodos , Monitoreo del Ambiente/normas , Monitoreo del Ambiente/estadística & datos numéricos , Estudios de Factibilidad , Peces/sangre , Modelos Biológicos , Preparaciones Farmacéuticas/sangre , Preparaciones Farmacéuticas/química , Relación Estructura-Actividad Cuantitativa , Medición de Riesgo , Contaminantes Químicos del Agua/sangre , Contaminantes Químicos del Agua/química , Contaminantes Químicos del Agua/toxicidadRESUMEN
Proteinase 3 (PR3) is a major autoantigen in anti-neutrophil cytoplasmic antibodies (ANCA)-associated systemic vasculitis (AASV), and the proportion of neutrophils expressing PR3 on their membrane (mPR3+) is increased in AASV. We have shown recently that mPR3 and CD177 are expressed on the same cells in healthy individuals. In this study we try to elucidate mechanisms behind the increased mPR3 expression in AASV and its relationship to CD177. All neutrophils in all individuals were either double-positive or double-negative for mPR3 and CD177. The proportion of double-positive neutrophils was increased significantly in AASV and systemic lupus erythematosus patients. The proportion of mPR3+/CD177+ cells was not correlated to general inflammation, renal function, age, sex, drug treatment and levels of circulating PR3. AASV patients had normal levels of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Pro-PR3 was found to constitute 10% of circulating PR3 but none of the mPR3. We found increased mRNA levels of both PR3 and CD177 in AASV, but they did not correlate with the proportion of double-positive cells. In cells sorted based on membrane expression, CD177-mRNA was several-fold higher in mPR3+ cells. When exogenous PR3 was added to CD177-transfected U937 cells, only CD177+ cells bound PR3 to their membrane. In conclusion, the increased membrane expression of PR3 found in AASV is not linked directly to circulating PR3 or PR3 gene transcription, but is dependent upon CD177 expression and correlated with the transcription of the CD177 gene.
Asunto(s)
Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/enzimología , Membrana Celular/metabolismo , Isoantígenos/fisiología , Glicoproteínas de Membrana/fisiología , Mieloblastina/biosíntesis , Neutrófilos/enzimología , Receptores de Superficie Celular/fisiología , Adulto , Anciano , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/sangre , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/inmunología , Artritis Reumatoide/sangre , Artritis Reumatoide/enzimología , Artritis Reumatoide/inmunología , Donantes de Sangre , Inducción Enzimática , Femenino , Proteínas Ligadas a GPI , Regulación de la Expresión Génica , Factor Estimulante de Colonias de Granulocitos/sangre , Factor Estimulante de Colonias de Granulocitos y Macrófagos/sangre , Hemoglobinuria Paroxística/sangre , Hemoglobinuria Paroxística/enzimología , Hemoglobinuria Paroxística/inmunología , Humanos , Isoantígenos/biosíntesis , Isoantígenos/genética , Trasplante de Riñón , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/enzimología , Lupus Eritematoso Sistémico/inmunología , Masculino , Glicoproteínas de Membrana/biosíntesis , Glicoproteínas de Membrana/genética , Persona de Mediana Edad , Mieloblastina/genética , Mieloblastina/farmacología , Neutrófilos/inmunología , ARN Mensajero/biosíntesis , ARN Mensajero/sangre , Receptores de Superficie Celular/biosíntesis , Receptores de Superficie Celular/genética , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/genética , Transcripción Genética , Células U937/efectos de los fármacos , Células U937/enzimologíaRESUMEN
Anti-neutrophil cytoplasmic antibodies against proteinase 3 (PR3-ANCA) are used as diagnostic tools for patients with small vessel vasculitis (AASV). We have produced chimeric mouse/human PR3 molecules and investigate changes in reactivity over time and the possible relationship between epitope specificity and clinical course. Thirty-eight PR3-ANCA-positive patients diagnosed between 1990 and 2003 were followed until December 2005. Plasma was collected at each out-patient visit and older samples were retrieved retrospectively. Patients reacted with multiple epitopes at the time of diagnosis. At subsequent relapses 12 patients shifted reactivity, in 11 cases from epitopes located in the C-terminal towards epitopes in the N-terminal. Patients with reactivity against N-terminal parts of PR3 at diagnosis had a significantly lower relapse rate, 30% compared to 78% in the group with predominantly C-terminal reactivity (P = 0.04). The reactivity pattern did not correlate to outcome measured as death, end-stage renal disease or vasculitis activity index score (VDI) at 5 years. Further research is necessary to conclude if this is a general phenomenon.
Asunto(s)
Anticuerpos Anticitoplasma de Neutrófilos/inmunología , Especificidad de Anticuerpos/inmunología , Enfermedades Autoinmunes/inmunología , Epítopos/inmunología , Mieloblastina/inmunología , Vasculitis/inmunología , Adolescente , Adulto , Anciano , Anticuerpos Anticitoplasma de Neutrófilos/sangre , Enfermedades Autoinmunes/sangre , Enfermedades Autoinmunes/mortalidad , Enfermedades Autoinmunes/terapia , Niño , Epítopos/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mieloblastina/metabolismo , Estudios Prospectivos , Estructura Terciaria de Proteína , Estudios Retrospectivos , Vasculitis/sangre , Vasculitis/mortalidad , Vasculitis/terapiaRESUMEN
We present a simple and robust scheme for biosensing with an ultralow limit-of-detection down to several pg cm(-2) (or several tens of attomoles cm(-2)) based on optical label-free biodetection with localized surface plasmon resonances. The scheme utilizes cost-effective optical components and comprises a white light source, a properly functionalized sensor surface enclosed in a simple fluidics chip, and a spectral analyzer. The sensor surface is produced by a bottom-up nanofabrication technique with hole mask colloidal lithography. Despite its simplicity, the method is able to reliably detect protein-protein binding events at low picomolar and femtomolar concentrations, which is exemplified by the label-free detection of the extracellular adherence protein (EAP) found on the outer surface of the bacterium Staphylococcus aureus and of prostate-specific antigen (PSA), which is believed to be a prostate cancer marker. These experiments pave the way towards an ultra-sensitive yet compact biodetection platform for point-of-care diagnostics applications.
Asunto(s)
Proteínas Bacterianas/análisis , Antígeno Prostático Específico/análisis , Proteínas de Unión al ARN/análisis , Staphylococcus aureus/química , Resonancia por Plasmón de Superficie/métodos , Diseño de Equipo , Humanos , Límite de Detección , Masculino , Resonancia por Plasmón de Superficie/economía , Resonancia por Plasmón de Superficie/instrumentaciónRESUMEN
Treated sewage effluents often contain a mixture of estrogenic compounds in low concentrations. The total combined activity of these, however, may be sufficiently high to affect the reproduction of aquatic vertebrates. The introduction of advanced treatment technologies has been suggested as a way to remove micro-contaminants, including estrogenic substances. In this study, one municipal influent was treated with six different processes in parallel on a semi-large scale in order to assess their potential to reduce substances that could contribute to estrogenic effects in male fish. The effluent from a conventional, activated sludge treatment line was compared to a similarly treated effluent with a final sand-filtering step. The addition of ozonation (15 g O(3)/m(3)), a moving bed biofilm reactor (MBBR) or both in combination was also evaluated. There was also a separate treatment line that was based on a membrane bioreactor. A small battery of hepatic estrogen-responsive genes was measured in the exposed fish using quantitative PCR. Concentrations of steroid estrogens and estrogenic phenols in the effluents were measured by GC-ECNI-MS. The ozonated effluents were the only tested effluents for which all measured biological effects in exposed fish were removed. Chemical data suggested that the MBBR technology was equally effective in removing the analyzed estrogens; however, elevated expression of estrogen-responsive genes suggested that some estrogenic substances were still present in the effluent. The membrane bioreactor removed most of the measured estrogens and it reduced the induction of the estrogen-responsive genes. However, fish exposed to this effluent had significantly enlarged livers. Given that the same influent was treated in parallel with a broad set of technologies and that the chemical analyses were combined with an in vivo assessment of estrogenic responses, this study provides valuable input into the assessment of advanced treatment processes for removing estrogenic substances.
Asunto(s)
Estrógenos/análisis , Estrógenos/toxicidad , Expresión Génica/efectos de los fármacos , Oncorhynchus mykiss/genética , Aguas del Alcantarillado/química , Eliminación de Residuos Líquidos/métodos , Animales , Biodegradación Ambiental , Reactores Biológicos , Exposición a Riesgos Ambientales , Monitoreo del Ambiente , Marcadores Genéticos , MasculinoRESUMEN
OBJECTIVE: To investigate accidental falls and near fall incidents in people with multiple sclerosis with respect to clinical variables and the predictive values of four tests. DESIGN: A longitudinal, multi-centred cohort study with prospectively collected falls. PROCEDURES: Self-reported incidents during the three months following a standardized test procedure. SUBJECTS: Seventy-six people with multiple sclerosis and an Expanded Disability Status Scale score between 3.5 and 6.0. MAIN OUTCOME MEASURES: Berg Balance Scale, Timed Up and Go cognitive, Four Square Step Test (FSST) and 12-item Multiple Sclerosis Walking Scale. RESULTS: Forty-eight people (63%) registered 270 falls. Most falls occurred indoors during activities of daily life. We found a correlation of r(s)=0.57 between near falls and falls, and of r(s) = 0.82 between registered and retrospectively recalled falls. Fallers and non-fallers differed significantly regarding Expanded Disability Status Score (odds ratio (OR) 1.99, 95% confidence interval (CI) 1.22; 3.40), spasticity (OR 1.14, CI 1.02; 1.31), proprioception (OR 2.50, CI 1.36; 5.12) and use of walking aids (OR 2.27, CI 1.23; 4.37). Reported use of walking aids both indoors and outdoors increased the odds of falling fivefold while disturbed proprioception increased the odds 2.5-15.6 times depending on severity. The odds of falling were doubled for each degree of increased Expanded Disability Status Score and more than doubled for each degree of increased spasticity. The Berg Balance Scale, use of walking aids and Timed Up and Go cognitive best identified fallers (73-94%) and proprioception, Expanded Disability Status Score, 12-item Multiple Sclerosis Walking Scale and Four Square Step Test best identified non-fallers (75-93%). CONCLUSIONS: In clinical practice, looking at the use of walking aids, investigating proprioception and spasticity, rating Expanded Disability Status Score and using Berg Balance Scale or Timed Up and Go cognitive all contribute when identifying fallers.
Asunto(s)
Accidentes por Caídas , Esclerosis Múltiple/complicaciones , Esclerosis Múltiple/fisiopatología , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Deambulación Dependiente , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/rehabilitación , Espasticidad Muscular/complicaciones , Espasticidad Muscular/fisiopatología , Equilibrio Postural/fisiología , Valor Predictivo de las Pruebas , Factores de Riesgo , Análisis y Desempeño de Tareas , Caminata/fisiologíaRESUMEN
Proteomic analyses were performed to identify regulated liver proteins in rainbow trout (Oncorhynchus mykiss) caged upstream and downstream from a sewage treatment works (STW). Two-dimensional gel electrophoresis, image analysis and FT-ICR mass-spectrometry revealed four regulated protein spots. The three down-regulated spots contained betaine aldehyde dehydrogenase, lactate dehydrogenase and an unidentified protein respectively. The only up-regulated spot consisted of both mitochondrial ATP synthase alpha-subunit and carbonyl reductase/20beta-hydroxysteroid dehydrogenase (CR/20beta-HSD). Further studies using quantitative PCR revealed a 13.5-fold induction of CR/20beta-HSD B mRNA following STW effluent exposure. The CR/20beta-HSD B gene was not regulated by 17alpha-ethinylestradiol, suggesting that its induction downstream from the STW is due to other factors than exposure to estrogens. Image analysis was initially performed on four gels from each group. These analyses suggested 15 regulated spots. However, validation of the 15 spots by increasing the number of replicates confirmed only four regulated spots. Hence, the present study also demonstrates the need for sufficient biological/technical replication in the interpretation of proteomic data.
Asunto(s)
Cortisona Reductasa/biosíntesis , Hígado/efectos de los fármacos , Hígado/enzimología , Oncorhynchus mykiss/metabolismo , Proteómica , Aguas del Alcantarillado , Contaminantes Químicos del Agua/toxicidad , Animales , Cortisona Reductasa/genética , Electroforesis en Gel Bidimensional , Inducción Enzimática/efectos de los fármacos , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , ATPasas de Translocación de Protón Mitocondriales/biosíntesis , ATPasas de Translocación de Protón Mitocondriales/genética , ARN Mensajero/metabolismo , Espectroscopía Infrarroja por Transformada de Fourier , Espectrometría de Masas en TándemRESUMEN
Several findings link proteinase 3 (PR3) to small vessel vasculitis. Besides being a major target of anti-neutrophil cytoplasm antibodies (ANCA), previous findings have shown increased circulating levels of PR3 in vasculitis patients, increased levels of neutrophil membrane-PR3 (mPR3) expression and a skewed distribution of the - 564 A/G polymorphism in the promotor region of the PR3 gene. In this study we elucidate how these three findings relate to each other. The plasma concentration of PR3 was measured by enzyme-linked immunosorbent assay (ELISA), mPR3 expression by fluorescence activated cell sorter (FACS) and the gene polymorphism by real-time polymerase chain reaction (PCR). We compared results from 63 patients with ANCA-associated systemic vasculitis (AASV) with 107 healthy blood donors. In accordance with previous reports, AASV patients had increased plasma concentrations of PR3 compared to healthy controls (mean 224 microg/l versus 155 microg/l, P < 0.0001). They also showed an increased number of mPR3-positive neutrophils (60%versus 42%, P < 0.001). However, contrary to a previous report, we found no skewed distribution of the polymorphism in PR3 gene. There was a weak correlation between mPR3 mean fluorescence intensity (MFI) and plasma PR3 among healthy controls and myeloperoxidase-ANCA (MPO-ANCA)-positive patients (r = 0.24, P = 0.015 and r = 0.52, P = 0.011, respectively). In conclusion, increased plasma PR3 and high expression of mPR3 are associated with small vessel vasculitis, but neither of them is a consequence of the - 564 A/G polymorphism of the PR3 gene promotor.
Asunto(s)
Neutrófilos/enzimología , Serina Endopeptidasas/análisis , Vasculitis/enzimología , Estudios de Casos y Controles , Membrana Celular/enzimología , Distribución de Chi-Cuadrado , Citometría de Flujo , Genotipo , Humanos , Mieloblastina , Fenotipo , Polimorfismo Genético , Regiones Promotoras Genéticas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Serina Endopeptidasas/sangre , Serina Endopeptidasas/genética , Vasculitis/genéticaRESUMEN
OBJECTIVE: To assess if activities of daily living (ADL), coping and quality of life could be improved in adults with muscular dystrophy through a comprehensive rehabilitation programme. DESIGN: Quasi-experimental, controlled clinical study comparing patients with similar age and disease aspects. SETTING: Two different counties in Sweden, being either study or control setting. SUBJECTS: The study group comprised 37 adults (21 women, 16 men; mean age 50 years), while the control group comprised 39 people (25 women, 14 men; mean age 46 years). INTERVENTIONS: Four rehabilitation sessions tailored to different medical, physical and psychosocial needs of the patients, comprising a total of 10 days over a period of 18 months. MAIN MEASURES: ADL, the Mental Adjustment to Cancer Scale measuring coping strategies, the Sickness Impact Profile measuring health-related quality of life, the Hospital Anxiety and Depression Scale, and the Psychosocial Well-being Questionnaire. RESULTS: No significant differences were found between groups with regard to the outcome measures. There was increased dependence on others in ADL after 18 months in both groups, but it was more pronounced in the control group. Furthermore, a clear trend was observed in the data with regard to coping patterns, the control group using more coping strategies such as 'Helplessness/hopelessness' (P= 0.057), 'Anxious preoccupation' (P = 0.085) and 'Fatalistic' (P= 0.073) when being compared to the study group. CONCLUSIONS: No apparent effects on ADL were found from the rehabilitation programme, although there was a tendency of reduction of maladaptive coping patterns in the study group. This initial study may provide the rationale and basis for a randomized controlled trial.
Asunto(s)
Actividades Cotidianas , Adaptación Psicológica , Distrofias Musculares/rehabilitación , Calidad de Vida , Adulto , Anciano , Ansiedad/epidemiología , Depresión/epidemiología , Evaluación de la Discapacidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Encuestas y CuestionariosRESUMEN
OBJECTIVE: To perform genetic linkage analysis in a family affected with ALS and frontotemporal dementia (FTD). METHODS: The authors performed a genome-wide linkage analysis of a four-generation, 50-member Scandinavian family in which five individuals were diagnosed with ALS and nine with FTD. Linkage calculations assuming autosomal dominant inheritance of a single neurodegenerative disease manifesting as either ALS or FTD with age-dependent penetrance were performed. Further analyses for ALS alone and FTD alone were performed. A parametric logarithm of odds (lod) score of 2.0 or greater was required for further study of a potential locus and crossover (haplotype) analysis. RESULTS: A new ALS-FTD locus was identified between markers D9s1870 and D9s1791 on human chromosome 9p21.3-p13.3. A maximum multipoint lod score of 3.00 was obtained between markers D9s1121 and D9s2154. Crossover analysis indicates this region covers approximately 21.8 cM, or 14Mb. CONCLUSIONS: A locus on chromosome 9p21.3-p13.3 is linked to ALS-FTD.
Asunto(s)
Esclerosis Amiotrófica Lateral/genética , Cromosomas Humanos Par 9/genética , Demencia/genética , Predisposición Genética a la Enfermedad/genética , Sitios de Carácter Cuantitativo/genética , Anciano , Femenino , Ligamiento Genético/genética , Marcadores Genéticos/genética , Haplotipos/genética , Humanos , Masculino , Persona de Mediana Edad , LinajeRESUMEN
OBJECTIVES: The aims of this study were to describe the quality of life in patients with multiple sclerosis (MS) given immunological treatment and in those not given immunological treatment and to investigate the relationship between impairment and quality of life. METHODS: Twenty nine patients given immunological treatment were matched with the same number of patients not given such treatment. Matching variables were sex, Kurtzke's Expanded Disability Status Scale (EDSS), years since diagnosis, and age (total n = 58). The patients were interviewed using the self-reported impairment checklist and they answered two questionnaires on quality of life, the 36-Item Short-Form Health Survey (SF-36) and the Subjective Estimation of Quality of Life (SQoL). RESULTS: The self-reported impairment checklist captured a more differentiated picture of the patients' symptoms of MS than the EDSS. Health related quality of life was markedly reduced, while the subjective quality of life was less affected. There was a stronger association between self-reported ratings of impairment and health related quality of life on the SF-36 than between impairment and global ratings of quality of life on the SQoL. Subjective quality of life on the SQoL was not directly dependent on impairment expressed in physical limitations. There were no statistically significant differences between the treated and untreated groups. A non-significant trend towards better health related quality of life was found in favour of the treated group with respect to emotional role, physical role, and social function on the SF-36. CONCLUSIONS: The self-reported impairment checklist and SF-36 proved to be valuable complements to the well established EDSS in describing the diverse symptoms of MS. Measuring both health related quality of life and subjective wellbeing provides valuable knowledge about the consequences of MS.
Asunto(s)
Estado de Salud , Esclerosis Múltiple/complicaciones , Esclerosis Múltiple/psicología , Calidad de Vida/psicología , Actividades Cotidianas , Adyuvantes Inmunológicos/administración & dosificación , Adulto , Anciano , Femenino , Encuestas Epidemiológicas , Humanos , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/tratamiento farmacológicoRESUMEN
The growing field of biotechnology is in constant need of binding proteins with novel properties. Not just binding specificities and affinities but also structural stability and productivity are important characteristics for the purpose of large-scale applications. In order to find such molecules, libraries are created by diversifying naturally occurring binding proteins, which in those cases serve as scaffolds. In this study, we investigated the use of a thermostable carbohydrate binding module, CBM4-2, from a xylanase found in Rhodothermus marinus, as a diversity-carrying scaffold. A combinatorial library was created by introducing restricted variation at 12 positions in the carbohydrate binding site of the CBM4-2. Despite the small size of the library (1.6 x 10(6) clones), variants specific towards different carbohydrate polymers (birchwood xylan, Avicel and ivory nut mannan) as well as a glycoprotein (human IgG4) were successfully selected for, using the phage display method. Investigated clones showed a high productivity (on average 69 mg of purified protein/l shake flask culture) when produced in Escherichia coli and they were all stable molecules displaying a high melting transition temperature (75.7 +/- 5.3 degrees C). All our results demonstrate that the CBM4-2 molecule is a suitable scaffold for creating variants useful in different biotechnological applications.
Asunto(s)
Bacteriófagos , Metabolismo de los Hidratos de Carbono , Variación Genética , Xilosidasas/genética , Xilosidasas/metabolismo , Secuencia de Aminoácidos , Sitios de Unión , Rastreo Diferencial de Calorimetría , Dicroismo Circular , Secuencia de Consenso , Secuencia Conservada , Estabilidad de Enzimas , Ensayo de Inmunoadsorción Enzimática , Escherichia coli/genética , Escherichia coli/crecimiento & desarrollo , Escherichia coli/virología , Vectores Genéticos , Modelos Moleculares , Datos de Secuencia Molecular , Biblioteca de Péptidos , Filogenia , Estructura Secundaria de Proteína , Proteínas Recombinantes de Fusión/metabolismo , Rhodothermus/enzimología , Selección Genética , Homología de Secuencia de Aminoácido , Especificidad por Sustrato , Xilosidasas/químicaRESUMEN
Autoantibodies against proteinase 3 (PR3) and myeloperoxidase (MPO) (ANCA = anti-neutrophil cytoplasmic antibodies) are used as diagnostic tools for patients with small vessel vasculitis. ANCA are detected by different assays, but the correlation between the results of these assays is generally poor. The overall aim of the study was to provide a framework for the future development of new assays with an increased diagnostic yield. In order to express discrete epitopes of human PR3 (hPR3), the nonantigenic molecules murine PR3 (mPR3) and human leucocyte elastase (HLE) were used as a framework. We constructed recombinant chimeric vectors and were able to produce 6 hPR3/mPR3 proteins and 3 hPR3/HLE proteins. Anti-PR3 monoclonal antibodies differed in their binding pattern to the chimeras, but no distinct binding region could be identified for any monoclonal antibody. The recombinant hPR3/mPR3 were also tested in ELISA with sera from patients with Wegener's granulomatosis with renal involvement. The results show that patients have antibodies to different constructs, indicating that the patients vary in their antibody repertoire from the beginning of the disease, and that patients may have antibodies from a broad range of clones early in the course of the disease. Recombinant hPR3/mPR3 chimeric proteins have a potential to be used as antigens in future ANCA assays.
Asunto(s)
Anticuerpos Anticitoplasma de Neutrófilos/sangre , Mapeo Epitopo/métodos , Granulomatosis con Poliangitis/diagnóstico , Serina Endopeptidasas/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Anticitoplasma de Neutrófilos/inmunología , Anticuerpos Monoclonales/inmunología , Autoanticuerpos/inmunología , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática/métodos , Vectores Genéticos , Granulomatosis con Poliangitis/inmunología , Humanos , Elastasa de Leucocito/genética , Ratones , Datos de Secuencia Molecular , Mieloblastina , Peroxidasa/inmunología , Proteínas Recombinantes de Fusión/inmunología , Proteínas Recombinantes/inmunología , Serina Endopeptidasas/genética , TransfecciónRESUMEN
A prospective study of 474 dogs, 145 cats, and 66 wild red foxes submitted for necropsy to the Departments of Pathology at the National Veterinary Institute and the Swedish University of Agricultural Sciences, Uppsala, Sweden, was conducted to examine for the presence of Pneumonyssoides caninum, the canine nasal mite. Pneumonyssoides caninum (P. caninum) was found in 95 (20%) of the dogs but in none of the cats or foxes. The median number of P. caninum mites per infected dog was 13 (range, 1 to 250). Dogs older than 3 years of age were more often infected with P. caninum than younger dogs, and large-breed dogs were more often infected than small-breed dogs. No sex predisposition was found.
Asunto(s)
Enfermedades de los Gatos/epidemiología , Enfermedades de los Perros/epidemiología , Zorros/parasitología , Infestaciones por Ácaros/veterinaria , Ácaros , Enfermedades Nasales/veterinaria , Animales , Enfermedades de los Gatos/parasitología , Gatos , Enfermedades de los Perros/parasitología , Perros , Femenino , Masculino , Infestaciones por Ácaros/epidemiología , Enfermedades Nasales/epidemiología , Enfermedades Nasales/parasitología , Prevalencia , Estudios Prospectivos , Suecia/epidemiologíaAsunto(s)
Trastornos de Ansiedad/complicaciones , Trastornos Psicofisiológicos/etiología , Trastornos Somatomorfos/etiología , Estrés Psicológico/complicaciones , Trastornos de Ansiedad/diagnóstico , Trastornos de Ansiedad/terapia , Diagnóstico Diferencial , Humanos , Relaciones Médico-Paciente , Trastornos Psicofisiológicos/diagnóstico , Trastornos Psicofisiológicos/psicología , Trastornos Psicofisiológicos/terapia , Trastornos Somatomorfos/diagnóstico , Trastornos Somatomorfos/psicología , Trastornos Somatomorfos/terapia , Estrés Psicológico/diagnóstico , Estrés Psicológico/terapiaRESUMEN
Antibodies to the canine nasal mite, Pneumonyssoides caninum, were demonstrated by ELISA in sera from four experimentally and 77 naturally infected dogs employing a crude P. caninum antigen. In sera from the four experimentally infected dogs, antibodies to P. caninum were first detected on day 11 post-inoculation (p.i.). Optical density (OD) values remained high throughout the observation period of 14 weeks. Two major protein bands with apparent molecular weights of 83 and 74kDa were visible by western blot (WB) from day 11 p.i. On day 14 p.i., another three major protein bands at 44, 37, and 34kDa were visible. The protein pattern then remained essentially constant until the end of the experiment except for some weak bands between 250 and 30kDa which were sometimes visible. In sera obtained from a non-inoculated control dog, no P. caninum antibodies were detected, neither by the ELISA nor by the WB. With sera from 77 naturally infected dogs with a verified diagnosis of P. caninum infection, the OD values varied between 0.24 and 0.95. When sera from four of these dogs were analysed by WB, the protein pattern observed was equivalent with that seen with sera from the experimentally infected dogs on day 25 p.i. Sera from four experimental Beagles, in which no P. caninum mites were found at necropsy, were also analysed by the P. caninum ELISA, the OD values demonstrated never exceeded 0.15. In addition, 48 sera obtained from dogs infected with or allergic to other arthropods were used for studies of possible cross-reactivity. With 10 sera, elevated OD values were found by the ELISA. Eight of them showed a similar banding pattern by the WB as did the experimentally infected dogs on day 25 p.i. This was, therefore, interpreted as an effect of a concurrent P. caninum infection.
Asunto(s)
Anticuerpos/sangre , Enfermedades de los Perros/parasitología , Infestaciones por Ácaros/veterinaria , Ácaros/inmunología , Enfermedades Nasales/veterinaria , Animales , Anticuerpos/inmunología , Anticuerpos Monoclonales , Western Blotting/veterinaria , Reacciones Cruzadas , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/inmunología , Perros , Electroforesis en Gel de Poliacrilamida/veterinaria , Ensayo de Inmunoadsorción Enzimática/veterinaria , Femenino , Mediciones Luminiscentes , Masculino , Infestaciones por Ácaros/diagnóstico , Infestaciones por Ácaros/inmunología , Enfermedades Nasales/diagnóstico , Enfermedades Nasales/parasitologíaRESUMEN
The peripheral lymphocytes of 10 patients referred to as mercury intolerant and 9 patients referred to as tolerant with regard to presence or absence of psychosomatic symptoms when percutaneously exposed to low patch test doses of mercury were stimulated in vitro with four metal salts. In addition, cells from 7 subjects with no anamnestic mercury intolerance or allergy to metals as well as free from dental alloys were included as controls. Lymphocyte transformation test was done by in vitro challenge with five concentrations of gold sodium thiosulfate, nickel chloride, palladium chloride, and seven concentrations of mercuric chloride. Stimulation with palladium chloride and mercuric chloride showed a difference between the mercury-intolerant and -tolerant patients on one hand and the controls on the other, but there was no difference between the two patient groups. With regard to nickel sulfate, there was a significant dose-dependent stimulation in all the three groups but no difference between the groups could be seen. Gold sodium thiosulfate did not stimulate the lymphocytes at all. Based on these results, we therefore conclude that lymphocyte transformation test performed with the four metal salts cannot be used to further differentiate between mercury-intolerant and -tolerant patients.
Asunto(s)
Alérgenos/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Activación de Linfocitos , Cloruro de Mercurio/efectos adversos , Adulto , Anciano , Análisis de Varianza , Estudios de Casos y Controles , Dermatitis Alérgica por Contacto/inmunología , Relación Dosis-Respuesta a Droga , Femenino , Tiosulfato Sódico de Oro/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Níquel/efectos adversos , Paladio/efectos adversos , Pruebas del Parche , Valor Predictivo de las PruebasRESUMEN
Records of 105 dogs with pronounced eosinophilia (>2.2 x 10(9) eosinophils/litre) were evaluated in a retrospective study to determine diseases associated with the abnormality in dogs in Sweden. Inflammatory disease in organs with large epithelial surfaces, such as the gut, lungs or skin, was found in 36 per cent of the dogs. A further one-quarter of the 105 cases were placed in the 'miscellaneous' category, which comprised various diseases found at low frequency. The most well defined diagnosis was pulmonary infiltrates with eosinophils in 12 per cent of the dogs. A further 11 per cent had parasitic disease caused by either sarcoptic mange or nasal mite. No atopic dog was found and rottweilers were over-represented in most disease groups. Pronounced eosinophilia, in many cases transient, seems to be associated with a variety of disorders in dogs. In the present study, rottweilers appeared to be more prone to a high eosinophil response than other breeds.